GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Olipass Corp (XKRX:244460) » Definitions » Margin of Safety % (DCF FCF Based)

Olipass (XKRX:244460) Margin of Safety % (DCF FCF Based) : N/A (As of Apr. 14, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Olipass Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Olipass's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Olipass's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Olipass's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Olipass's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Olipass's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Olipass's Margin of Safety % (DCF FCF Based) falls into.


;
;

Olipass Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Olipass's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Olipass Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Olipass Corp (XKRX:244460) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
XKRX:179530 XKRX:188260 XKRX:341170 XKRX:344860 XKRX:950220 XKRX:352770 XKRX:251280 XKRX:065650 XKRX:266470 XKRX:322970 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
16-4, 16 Beon-gil, Dongbaek Jungang-ro, Ace Dongbaek Tower 20th Floor, Giheung-gu, Yongin, KOR, 17015
Website
https://www.olipass.com
Olipass Corp is a South Korea based biotechnology company engaged in developing its platform OliPass PNA which focuses on introducing cationic lipid moiety onto nucleobase. Its pipeline products include SC Injection, Hyper Cholesterolemia, Chemo/Radio-sensitizer, and Type II Diabetes among others.

Olipass Headlines

No Headlines